Decrease in mortality in Lynch syndrome families because of surveillance

被引:221
作者
De Jong, AE
Hendriks, YMC
Kleibeuker, JH
De Boer, SY
Cats, A
Griffioen, G
Nagengast, FM
Nelis, FG
Rookus, MA
Vasen, HFA
机构
[1] Leiden Univ, Med Ctr, Netherlands Fdn Detect Hereditary Tumors, NL-2333 AA Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Gastroenterol, NL-2333 AA Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Human & Clin Genet, NL-2333 AA Leiden, Netherlands
[4] Univ Groningen, Dept Gastroenterol, NL-9700 AB Groningen, Netherlands
[5] Univ Med Ctr Groningen, Groningen, Netherlands
[6] Rijnstate Hosp Arnhem, Arnhem, Netherlands
[7] Netherlands Canc Inst, Amsterdam, Netherlands
[8] Univ Med Ctr Nijmegen, Nijmegen, Netherlands
[9] Sophia Hosp, Zwolle, Netherlands
关键词
D O I
10.1053/j.gastro.2005.11.032
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Lynch syndrome family members have a high risk of developing colorectal (CRC), endometrial (EC), and other cancers. A large-scale surveillance program was introduced in The Netherlands in the late 1980s. The aims of the study were to evaluate the effectiveness of this program by assessing mortality because of CRC and EC before and after 1990 and to compare mortality because of all cancers (except CRC/EC) with mortality in the general population. Methods: Family members with at least 50% probability of being a carrier were selected for the study. The standardized mortality ratio (SMR) because of cancer and the absolute excess risk of death (AER) were calculated. Results: In the total cohort (N = 2788), 445 subjects had died because of cancer. The 3 most frequent causes of cancer-related deaths were CRC (50.3%), EC (6.7%), and brain tumors (6.7%). A significant decrease (70%) in SMR for CRC over time was observed (P <.001); the SMR for EC showed no decreasing trend over time. A significantly increased SMR was found for cancer of the small bowel (SMR = 18.3), brain (SMR = 9.1), kidney/ureter (SMR = 5.9), ovarium (SMR = 2.3), pancreas (SMR = 2.2), and stomach (SMR = 2.1). The AER was significantly increased for brain tumors only. Conclusions: Since the introduction of surveillance, the mortality because of CRC has decreased. Except for brain tumors, we did not find a significantly increased AER for tumors other than CRC/EC.
引用
收藏
页码:665 / 671
页数:7
相关论文
共 31 条
  • [1] Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO
  • [2] 2-C
  • [3] Akiyama Y, 1997, CANCER RES, V57, P3920
  • [4] [Anonymous], IARC SCI PUBL
  • [5] Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer
    Boks, DES
    Trujillo, AP
    Voogd, AC
    Morreau, H
    Kenter, GG
    Vasen, HFA
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (02) : 198 - 200
  • [6] MUTATION IN THE DNA MISMATCH REPAIR GENE HOMOLOG HMLH1 IS ASSOCIATED WITH HEREDITARY NONPOLYPOSIS COLON-CANCER
    BRONNER, CE
    BAKER, SM
    MORRISON, PT
    WARREN, G
    SMITH, LG
    LESCOE, MK
    KANE, M
    EARABINO, C
    LIPFORD, J
    LINDBLOM, A
    TANNERGARD, P
    BOLLAG, RJ
    GODWIN, AR
    WARD, DC
    NORDENSKJOLD, M
    FISHEL, R
    KOLODNER, R
    LISKAY, RM
    [J]. NATURE, 1994, 368 (6468) : 258 - 261
  • [7] DIERGAARDE B, 2004, DIET LIFESTYLE MOL A, P91
  • [8] The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma
    Dove-Edwin, I
    Boks, D
    Goff, S
    Kenter, GG
    Garpenter, R
    Vasen, HFA
    Thomas, HJW
    [J]. CANCER, 2002, 94 (06) : 1708 - 1712
  • [9] THE HUMAN MUTATOR GENE HOMOLOG MSH2 AND ITS ASSOCIATION WITH HEREDITARY NONPOLYPOSIS COLON-CANCER
    FISHEL, R
    LESCOE, MK
    RAO, MRS
    COPELAND, NG
    JENKINS, NA
    GARBER, J
    KANE, M
    KOLODNER, R
    [J]. CELL, 1993, 75 (05) : 1027 - 1038
  • [10] Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations:: Impact on counseling and surveillance
    Hendriks, YMC
    Wagner, A
    Morreau, H
    Menko, F
    Stormorken, A
    Quehenberger, F
    Sandkuijl, L
    Moller, P
    Genuardi, M
    Van Houwelingen, H
    Tops, C
    Van Puijenbroek, M
    Verkuijlen, P
    Kenter, G
    Van Mil, A
    Meijers-Heijboer, H
    Tan, GB
    Breuning, MH
    Fodde, R
    Wijnen, JT
    Bröcker-Vriends, AHJT
    Vasen, H
    [J]. GASTROENTEROLOGY, 2004, 127 (01) : 17 - 25